Penny Stock Talk

GAXY: A Covid-19 play marrying technology and disinfectants to prevent Covid-19.
Brandon Nelson Nov 16,2020,16:30

Despite the recent positive news regarding Pfizer and Moderna's Covid-19 vaccine, the virus running rampant across the globe and will continue to do so until a vaccine is widely available sometime mid-next year at the earliest.

Pfizer and Moderna's stocks are already way up. But there are still small-cap Covid-19 plays with huge potential upside. Meet Galaxy Next Generation (OTCQB: GAXY):

The Play:

Lowest Buy Price (LBP): $.0080

Maximum Sell Price (MSP): $.065

Multiplier: 8x

Every $100 invested = $800 payout (short-term)

Hold: 30-45 days (if you decide to hold longer, approx. 1-2 years, it may payout much higher)

The Scoop:

Galaxy has taken major strides to land big contracts with high schools and other businesses across the US. These contracts are bringing in massive revenues that will surely lead to incredible share price increases and market capitalization. Another plus is that increased revenues will allow GAXY to pay down their notes (debt), and possibly buyback shares and retire them to their treasury, leading to a further increase in share price. Currently, GAXY is diligently working to install protective equipment such as their patented Cov-Shield products. On February 11, 2019, GAXY’s share price hit $3.99. Currently you can purchase shares for under $.01, yes you read that correctly, less than 1 penny. The market is beginning to heat up and this stock is ready to go. My suggestion, get in now before the price skyrockets and net yourself a considerable profit.

Key Takeaways:

- Revenue increased 89% to $1.2 million

- Deferred Revenue of $1.6 million

- Total Assets increased to $5.2 million

- Backlog increased to $2.0 million

- Company has a goal to get on a major U.S. National Exchange within the next 12 months (this is huge)

- Company can eventually pay down debt/notes (buyback shares), and then they can retire those shares which in turn can boost share price (pps)

The Company:

Galaxy Next Generation Inc., has combined its manufacturing and distributing learning technologies/audio solutions software with Covid-19 disinfectant and prevention products. The company provides interactive learning technology solutions that allows the presenter and participant to engage in a fully collaborative instructional environment. Galaxy's products include Galaxy's own private-label interactive touch screen panel as well as numerous other national and international branded peripheral and communication devices. Galaxy's distribution channel consists of 22+ resellers across the U.S. who primarily sell the Company's products within the commercial and educational market. Galaxy does not control where resellers focus their resell efforts, although generally, the K-12 education market is the largest customer base for Galaxy products - comprising nearly 90% of Galaxy's sales.

The Technicals:

Outstanding Shares: 2.19 Billion

Market Cap: $21.07 Million

EPS: -0.46

52-Wk High: $.70


I am not a paid analyst or professional trader. All information that I provide pertaining to the penny stock market is purely educated estimates based on my own research and due diligence. Investing can be very risky and it is up to the investor/stock trader to make gooddecisions when trading. I am not responsible for your choices.

CapitalWatch Disclaimer:

The opinions expressed in this article do not reflect the position of CapitalWatch or its journalists. CapitalWatch has no business relationship with any company whose stock is mentioned in this article. Information provided is for educational purposes only and does not constitute financial, legal, or investment advice.

Topics:covid-19, coronavirus, small-cap, penny stock GAXY